Peking University Cancer Hospital — Beijing, Beijing Municipality

Public research footprint of Peking University Cancer Hospital, compiled from the ClinicalTrials.gov public registry.

305

Registered studies

147

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Cancer · Advanced Solid Tumors · Colorectal Cancer · Metastatic Non Small Cell Lung Cancer

Recently updated registry entries

NCT07127822 — Assessing Iparomlimab and Tuvonralimab in Recurrent or Metastatic MSI-H/dMMR Gastric… (Recruiting)
NCT07745322 — Spatial MSC Index for Predicting Anti-PD-1 Efficacy in Esophageal Cancer (Active Not Recruiting)
NCT07737600 — A Study of MRG007 Combination Therapy for Advanced Colorectal Cancer (Not Yet Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Peking University Cancer Hospital?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 05, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.